Hypermethylation of the TSPOAP1-AS1 Promoter May Be Associated with Obesity in Overweight/Obese Korean Subjects

• Published in: International journal of molecular sciences 2020-05, Vol.21 (9), p.3307
• Main Authors: Yim, Nam-Hui, Cha, Min Ho, Kim, Myung Sunny
• Format: Article
• Language: English
• Subjects: Adipocytes; Aged; Antisense RNA; Arteriosclerosis; Atherosclerosis; Binding sites; Biomarkers; Bisulfite; Body mass index; Body size; Body weight; Cancer; Cardiovascular disease; Cardiovascular diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL - blood; Correlation analysis; Deoxyribonucleic acid; Diabetes mellitus; DNA; DNA Methylation; DNA sequencing; Epigenesis, Genetic; Epigenetics; Female; Gene expression; Genetic Association Studies; Genomes; Homeostasis; Humans; Hypertension; Hypotheses; Indexing; LDL-cholesterol; Low density lipoprotein; Male; Middle Aged; Obesity; Obesity - blood; Obesity - genetics; Overweight - blood; Overweight - genetics; Phenotypes; Promoter Regions, Genetic; Prostate; Proteins; Republic of Korea; RNA, Long Noncoding - genetics; Stroke; Studies; total cholesterol; Transcription factors; TSPOAP1-AS1
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms21093307

Obesity is a major chronic disease associated with the risk of serious cardiovascular or endocrinal diseases, such as hypertension, diabetes, atherosclerosis and stroke. Considerable interest has been directed towards the potential effects of epigenetic variations in obesity. In this study, we evaluated DNA methylation level at the promoter region of the gene encoding TSPO-associated protein 1 antisense RNA 1 (TSPOAP1-AS1) in 80 overweight/obese subjects (body mass index (BMI) > 25) and 104 non-obese subjects who participated in the SOPI-Stroke study in Korea. DNA methylation was measured using bisulfite amplicon sequencing (BSAS). A general linear model or relative correlation was used to determine the effects of DNA methylation on obesity and obese phenotypes. Notably, the mean level of DNA methylation was significantly higher in the overweight/obese group than in the non-obese group (18.62% vs. 17.18%). Further analyses revealed significant positive correlations of the BMI, the serum total cholesterol and low-density lipoprotein cholesterol levels with the DNA methylation level ( = 0.0493, = 0.003, and = 0.0094, respectively). The study findings suggest an association between DNA methylation at the promoter and overweight/obesity. Accordingly, methylation in this promoter region might be a potential predictor of obesity.